Egoropal

GIF decision: Withdrawal from market, Marketing prohibition

What does this decision mean?

  • Wycofanie z obrotu — Some of the products covered by the decision were withdrawn from the market — please return them to the pharmacy/distributor.
  • Zakaz wprowadzania — Selected batches are subject to a marketing prohibition — the product cannot be distributed to pharmacies.

Serious deficiencies were detected in aseptic manufacturing, creating a threat to product quality. A risk to patients' health or life cannot be excluded, particularly due to the parenteral injectable form of the medicine. Potential effects: infection, severe injection-related complications, lack of therapeutic efficacy.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Egoropal
Risk Level
Critical
Manufacturer
Egis Pharmaceuticals PLC z siedzibą w Budapeszcie, Węgry
Batch Number
4400718, 4500766, 4501274, 4400293, 4400851, 4500598, 4500832, 4500892, 4501060, 4501376
Notice Date
08.01.2026
View official statement

Related

Other Notices